MedTrace Logo

An Evaluation of Epic EHR AI Outpatient Chart Summarization

NCT07438743 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2026-03-06

No results posted yet for this study

Summary

This is a RCT of 284 outpatient physicians at a large academic health system, randomized 1:1 to an electronic health record (EHR) produced generative AI outpatient chart summarization tool or a usual-care control group. The 90 day study will observe the effects of the tool prior to system-wide roll out of the tool.

Conditions

  • Quality Improvement

Interventions

OTHER

GenAI Chart Summarization

Epic's generative AI chart summarization tool summarizes a subset of a patient's notes. Use of the tool is optional and intended solely to provide a summary for providers and does not provide clinical decision support. The system automatically selects recent notes or a provider can manually select specific notes of interest. The number of notes summarized is limited by the character constraints of the EHR, 24,000 English characters or 30 notes. The system uses AI to generate a short summary of relevant information. The summaries are meant to be used as a tool to aid providers and are not intended to be placed in clinical notes. The summaries created are currently not stored in the patient's chart.

Sponsors & Collaborators

Principal Investigators

  • John N Mafi, MD, MPH · Division of General Internal Medicine & Health Services Research, David Geffen School of Medicine at the University of California, Los Angeles

  • Paul J Lukac, MD, MBA, MS · UCLA Health Information Technology, UCLA Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-23
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07438743 on ClinicalTrials.gov